Clarke Neumann Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Clarke Neumann.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Clarke Neumann. Clarke Neumann is VP & General Counsel in SEQUENOM INC ($SQNM) and General Counsel and Secretary in PROGENITY, INC. ($PROG) and See Remarks in PROGENITY, INC. ($PROG).
Latest Insider Trading Transactions of Clarke Neumann
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 19 2021 | PROG | PROGENITY, INC. | NEUMANN CLARKE | See Remarks | Option Exercise | A | 3.41 | 183,265 | 624,934 | 183,265 | |
Apr 19 2021 | PROG | PROGENITY, INC. | NEUMANN CLARKE | See Remarks | Grant | A | 0.00 | 87,356 | 0 | 138,091 | 50.7 K to 138.1 K (+172.18 %) |
Apr 19 2021 | PROG | PROGENITY, INC. | NEUMANN CLARKE | See Remarks | Option Exercise | A | 3.41 | 183,265 | 624,934 | 183,265 | |
Apr 19 2021 | PROG | PROGENITY, INC. | NEUMANN CLARKE | See Remarks | Grant | A | 0.00 | 87,356 | 0 | 138,091 | 50.7 K to 138.1 K (+172.18 %) |
Mar 17 2021 | PROG | PROGENITY, INC. | NEUMANN CLARKE | See Remarks | Option Exercise | A | 4.73 | 89,137 | 421,618 | 89,137 | |
Mar 08 2021 | PROG | PROGENITY, INC. | NEUMANN CLARKE | General Counsel and ... | Payment of Exercise | F | 4.05 | 1,564 | 6,334 | 50,735 | 52.3 K to 50.7 K (-2.99 %) |
Feb 17 2021 | PROG | PROGENITY, INC. | NEUMANN CLARKE | General Counsel and ... | Payment of Exercise | F | 5.60 | 663 | 3,713 | 52,299 | 53 K to 52.3 K (-1.25 %) |
Dec 22 2020 | PROG | PROGENITY, INC. | NEUMANN CLARKE | General Counsel and ... | Payment of Exercise | F | 6.32 | 1,726 | 10,908 | 52,962 | 54.7 K to 53 K (-3.16 %) |
Aug 18 2020 | PROG | PROGENITY, INC. | NEUMANN CLARKE | General Counsel and ... | Option Exercise | A | 9.76 | 34,800 | 339,648 | 34,800 | |
Aug 18 2020 | PROG | PROGENITY, INC. | NEUMANN CLARKE | General Counsel and ... | Option Exercise | A | 9.88 | 19,422 | 191,889 | 19,422 | |
Aug 18 2020 | PROG | PROGENITY, INC. | NEUMANN CLARKE | General Counsel and ... | Option Exercise | A | 9.88 | 6,474 | 63,963 | 6,474 | |
Aug 18 2020 | PROG | PROGENITY, INC. | NEUMANN CLARKE | General Counsel and ... | Option Exercise | A | 9.88 | 19,423 | 191,899 | 19,423 | |
Aug 18 2020 | PROG | PROGENITY, INC. | NEUMANN CLARKE | General Counsel and ... | Option Exercise | A | 7.71 | 42,114 | 324,699 | 42,114 | |
Aug 18 2020 | PROG | PROGENITY, INC. | NEUMANN CLARKE | General Counsel and ... | Grant | A | 0.00 | 20,534 | 0 | 54,688 | 34.2 K to 54.7 K (+60.12 %) |
Feb 08 2012 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Option Exercise | A | 4.92 | 25,360 | 124,771 | 25,360 | |
Feb 08 2012 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Option Exercise | A | 4.92 | 17,640 | 86,789 | 17,640 | |
Feb 08 2012 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Payment of Exercise | F | 4.92 | 98 | 482 | 19,907 | 20 K to 19.9 K (-0.49 %) |
Feb 08 2012 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Grant | A | 0.00 | 235 | 0 | 20,005 | 19.8 K to 20 K (+1.19 %) |
Feb 08 2012 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Payment of Exercise | F | 4.92 | 390 | 1,919 | 19,770 | 20.2 K to 19.8 K (-1.93 %) |
Feb 08 2012 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Grant | A | 0.00 | 933 | 0 | 20,160 | 19.2 K to 20.2 K (+4.85 %) |
Feb 08 2012 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Payment of Exercise | F | 4.92 | 390 | 1,919 | 19,227 | 19.6 K to 19.2 K (-1.99 %) |
Feb 08 2012 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Grant | A | 0.00 | 933 | 0 | 19,617 | 18.7 K to 19.6 K (+4.99 %) |
Jul 19 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Payment of Exercise | F | 7.46 | 427 | 3,185 | 18,684 | 19.1 K to 18.7 K (-2.23 %) |
Jul 19 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Grant | A | 0.00 | 1,166 | 0 | 19,111 | 17.9 K to 19.1 K (+6.50 %) |
May 10 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Option Exercise | M | 4.23 | 100 | 423 | 0 | |
May 10 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Option Exercise | M | 4.23 | 100 | 423 | 100 | |
May 10 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Option Exercise | M | 4.23 | 911 | 3,854 | 200 | |
May 10 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Option Exercise | M | 1.87 | 5,000 | 9,350 | 52,500 | |
May 10 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Sell | S | 8.00 | 100 | 800 | 17,945 | 18 K to 17.9 K (-0.55 %) |
May 10 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Buy | M | 4.23 | 100 | 423 | 18,045 | 17.9 K to 18 K (+0.56 %) |
May 10 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Sell | S | 8.00 | 100 | 800 | 17,945 | 18 K to 17.9 K (-0.55 %) |
May 10 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Buy | M | 4.23 | 100 | 423 | 18,045 | 17.9 K to 18 K (+0.56 %) |
May 10 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Sell | S | 8.00 | 911 | 7,288 | 17,945 | 18.9 K to 17.9 K (-4.83 %) |
May 10 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Buy | M | 4.23 | 911 | 3,854 | 18,856 | 17.9 K to 18.9 K (+5.08 %) |
May 10 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Sell | S | 8.00 | 5,000 | 40,000 | 17,945 | 22.9 K to 17.9 K (-21.79 %) |
May 10 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Buy | M | 1.87 | 5,000 | 9,350 | 22,945 | 17.9 K to 22.9 K (+27.86 %) |
May 02 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Sell | S | 7.07 | 500 | 3,536 | 17,945 | 18.4 K to 17.9 K (-2.71 %) |
Apr 08 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Option Exercise | M | 1.87 | 5,000 | 9,350 | 57,500 | |
Apr 08 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Sell | S | 7.00 | 5,000 | 35,000 | 18,445 | 23.4 K to 18.4 K (-21.33 %) |
Apr 08 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Buy | M | 1.87 | 5,000 | 9,350 | 23,445 | 18.4 K to 23.4 K (+27.11 %) |
Apr 04 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Sell | S | 6.38 | 1,000 | 6,380 | 18,445 | 19.4 K to 18.4 K (-5.14 %) |
Mar 02 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Sell | S | 6.12 | 1,000 | 6,123 | 19,445 | 20.4 K to 19.4 K (-4.89 %) |
Feb 14 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Option Exercise | A | 6.70 | 13,997 | 93,780 | 13,997 | |
Feb 02 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Sell | S | 6.92 | 1,000 | 6,920 | 20,445 | 21.4 K to 20.4 K (-4.66 %) |
Jan 04 2011 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Sell | S | 8.06 | 1,000 | 8,060 | 21,445 | 22.4 K to 21.4 K (-4.46 %) |
Aug 04 2010 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Option Exercise | A | 5.92 | 14,583 | 86,331 | 14,583 | |
Aug 04 2010 | SQNM | SEQUENOM INC | NEUMANN CLARKE | VP & General Counse ... | Option Exercise | A | 5.92 | 10,417 | 61,669 | 10,417 | |
Feb 11 2009 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Option Exercise | A | 0.00 | 1,460 | 0 | 3,848 | |
Jan 20 2009 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Option Exercise | A | 25.15 | 23,107 | 581,141 | 23,107 | |
Jan 20 2009 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Option Exercise | A | 25.15 | 4,393 | 110,484 | 4,393 | |
Oct 14 2008 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Option Exercise | M | 9.00 | 1,334 | 12,006 | 0 | |
Oct 14 2008 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Buy | M | 9.00 | 1,334 | 12,006 | 23,112 | 21.8 K to 23.1 K (+6.13 %) |
Mar 11 2008 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Buy | P | 5.26 | 1,000 | 5,260 | 1,000 | 0 to 1,000 |
Jan 30 2008 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Option Exercise | A | 0.00 | 2,388 | 0 | 2,388 | |
Jan 30 2008 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Option Exercise | A | 8.16 | 18,650 | 152,184 | 18,650 | |
Jan 30 2008 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Option Exercise | A | 8.16 | 8,850 | 72,216 | 8,850 | |
Jul 12 2007 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Option Exercise | A | 4.93 | 2,976 | 14,672 | 2,976 | |
Jul 12 2007 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Option Exercise | A | 4.93 | 57,024 | 281,128 | 57,024 | |
May 10 2007 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Buy | P | 3.49 | 1,000 | 3,490 | 13,376 | 12.4 K to 13.4 K (+8.08 %) |
Jan 22 2007 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Grant | A | 0.00 | 5,044 | 0 | 12,043 | 7 K to 12 K (+72.07 %) |
Apr 04 2005 | SQNM | SEQUENOM INC | Neumann Clarke | VP & General Counse ... | Option Exercise | A | 1.03 | 8,250 | 8,498 | 8,250 |
Page: 1